XML 130 R33.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholders' Equity (Deficit) (Tables)
12 Months Ended
Dec. 31, 2024
Stockholders' Equity Note [Abstract]  
Schedule of Share-Based Payment Arrangement, Option, Activity

The following table summarizes the transactions involving options to purchase shares of the Company’s common stock:

 

   Shares   Weighted-
Average
Exercise Price
($)
 
Outstanding at December 31, 2022   310,692   $10.01 
Granted   -    - 
Cancelled/Expired   (209,758)  $10.00 
Exercised   -    - 
Outstanding at December 31, 2023   100,934   $10.05 
Granted   -    - 
Cancelled/Expired   (100,934)  $10.05 
Exercised   -    - 
Outstanding at December 31, 2024   -   $- 
Options vested and exercisable   -   $- 
Schedule of Warrants Purchase Exercise Price Range The following table summarizes the warrants outstanding on December 31, 2024, and the related prices for the warrants to purchase shares of the Company’s common stock:
            Weighted       Weighted 
        Weighted   average       average 
        average   exercise       exercise 
Range of   Number of   remaining   price of   Number of   price of 
exercise   warrants   contractual   outstanding   warrants   exercisable 
prices   outstanding   life (years)   warrants   exercisable   warrants 
$25.00    7,717    2.04    25.00    7,717    25.00 
 37.50    33,050    1.93    37.50    33,050    37.50 
      40,767    1.95   $31.26    40,767   $31.26 
Schedule of Stockholders' Equity Note, Warrants or Rights

The following table summarizes the transactions involving options to purchase shares of the Company’s common stock:

 

   Shares   Weighted-
Average
Exercise Price
($)
 
Outstanding at December 31, 2022   672,334   $30.68 
Granted   874   $2.50 
Exercised   -   $- 
Outstanding at December 31, 2023   673,208   $30.64 
Granted   -   $- 
Cancelled   (632,441)  $
(29,87
)
Exercised   -   $- 
Outstanding at December 31, 2024   40,767   $35.13